- Home
- NE vs RDNT Comparison
NE vs RDNT Comparison
Compare NE & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NE
- RDNT
- Stock Information
- Founded
- NE 1985
- RDNT 1985
- Country
- NE United States
- RDNT United States
- Employees
- NE N/A
- RDNT N/A
- Industry
- NE Other Specialty Stores
- RDNT Medical Specialities
- Sector
- NE Consumer Discretionary
- RDNT Health Care
- Exchange
- NE Nasdaq
- RDNT Nasdaq
- Market Cap
- NE 5.1B
- RDNT 4.6B
- IPO Year
- NE N/A
- RDNT 1986
- Fundamental
- Price
- NE $26.91
- RDNT $59.47
- Analyst Decision
- NE Buy
- RDNT Strong Buy
- Analyst Count
- NE 7
- RDNT 4
- Target Price
- NE $43.17
- RDNT $75.50
- AVG Volume (30 Days)
- NE 1.7M
- RDNT 665.7K
- Earning Date
- NE 02-17-2025
- RDNT 02-27-2025
- Dividend Yield
- NE 7.43%
- RDNT N/A
- EPS Growth
- NE N/A
- RDNT N/A
- EPS
- NE 2.96
- RDNT N/A
- Revenue
- NE $2,918,767,000.00
- RDNT $1,772,946,000.00
- Revenue This Year
- NE $17.37
- RDNT $14.62
- Revenue Next Year
- NE $5.93
- RDNT $8.96
- P/E Ratio
- NE $9.09
- RDNT N/A
- Revenue Growth
- NE 18.57
- RDNT 12.20
- 52 Week Low
- NE $26.84
- RDNT $36.47
- 52 Week High
- NE $52.16
- RDNT $93.65
- Technical
- Relative Strength Index (RSI)
- NE 24.68
- RDNT 35.95
- Support Level
- NE $31.00
- RDNT $60.23
- Resistance Level
- NE $30.36
- RDNT $64.66
- Average True Range (ATR)
- NE 1.20
- RDNT 2.72
- MACD
- NE -0.50
- RDNT -0.02
- Stochastic Oscillator
- NE 1.19
- RDNT 6.04
About NE Noble Corporation plc A
Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.